Generation Bio Co
(NAS:GBIO)
$
2.64
-0.13 (-4.69%)
Market Cap: 176.20 Mil
Enterprise Value: 53.21 Mil
PE Ratio: 0
PB Ratio: 1.61
GF Score: 34/100 Generation Bio Co at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript
Oct 27, 2021 / 09:00PM GMT
Release Date Price:
$20.52
(-4.34%)
Eun Yang
(Trades, Portfolio) LLC - Analyst
Good afternoon, everyone. I am hosting a fireside chat with Geoff McDonough, CEO of Generation Bio. Thank you, Geoff, for your participation in the discussion [in advance]. As you may know, many of you know, Generation Bio is working on potentially transformative gene therapy programs.
So before we go into the Q&As with Geoff -- Geoff, can you give us an overview of the platform as well as the key differentiation from your platform compared to other gene therapy companies?
Geoff McDonough
Generation Bio Co. - President and CEO
Yeah, for sure. First, Eun, thank you for the chance to be here with you. It's always fun to chat and I'm especially excited about what we're up to here at Generation Bio. This is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot